Arch Therapeutics, Inc. ARTH
0.00 0.00 0.00%
At close · May 2
52-week range unavailable
- Open
- 0.2014
- Prev close
- 0.0001
- Mkt cap
- 444
- Vol
- 1
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.2014
- Earnings
- Feb 12, 2025
MAX chart
Chart tools
Chart is warming up
The all-time price history for ARTH has not been loaded yet. Try again in a moment.
Altman Z-Score
-103.90 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.6×
P/S 52.8×
P/B -0.5×
P/FCF -1.2×
EV/EBITDA -2.4×
EV/Sales 124×
FCF Yield -84.5%
Gross Margin -3.2%
Operating Margin -6661.7%
Net Margin -9221.4%
ROE 93.0%
ROIC 268.3%
ROA -356.6%
Revenue 383.8%
Operating Income 11.6%
EPS (diluted) 36.2%
Free Cash Flow 24.2%
Current Ratio 0.2×
Quick Ratio 0.1×
Debt / Equity -0.7×
Net Debt / EBITDA -1.4×
Interest Coverage -1.6×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-09-30